Gene-sequencing giant Illumina (ILMN) said Tuesday that it had formed a new company called Helix that it hopes will bring genomics to the masses. “Helix will enable individuals to acquire an unprecedented amount of genetic information by providing affordable sequencing and database services for consumer samples brought through third party partners, driving the creation of an ecosystem of consumer applications,” Illumina explained in its press
As the market bounces back after five straight sessions of losses, here’s a look at four IBD 50 stocks that could bounce back after finding support at their moving averages: United Therapeutics (UTHR), Ellie Mae (ELLI), Epam Systems (EPAM) and Illumina (ILMN). United Therapeutics staged a huge upside reversal in the stock market today, falling nearly 8% before moving to higher ground as it found support at its 200-day line. The biotech is working
Illumina (ILMN) surpassed second quarter earnings estimates late Tuesday but missed on revenue for the first time in six years. Analysts expected a beat-and-raise from the maker of gene sequencing systems, so its shares suffered in the stock market today. Illumina stock gapped down 8.4% in huge volume on Wednesday, breaching its 50-day moving average intraday. But the stock was able to recover some of those losses and is now back above that key